CAS: 1342278-01-6 - RKI-1447
Ref: IN-DA009CEL
| 10mg | 119.00 € | ||
| 50mg | 314.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
RKI-1447
CAS:1342278-01-6
RKI-1447 is a potent inhibitor of ROCK1 and ROCK2. It has anti-invasive and antitumor activities.
Formula:
C16H14N4O2S
Purity:
98% - 99.73%
Color and Shape:
Solid
Molecular weight:
326.37
Ref: TM-T1898
| 5mg | 51.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 184.00 € | ||
| 50mg | 305.00 € | ||
| 100mg | 404.00 € | ||
| 200mg | 509.00 € | ||
| 500mg | 822.00 € | ||
| 1mL*10mM (DMSO) | 57.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
RKI-1447
Controlled ProductCAS:1342278-01-6
Applications RKI-1447 is a potent and selective ROCK1 and ROCK2 inhibitor with significant anti-invasive and …
Formula:
C16H14N4O2S
Color and Shape:
Neat
Molecular weight:
326.37
Ref: TR-R550000
| 1mg | 92.00 € | ||
| 5mg | 109.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Ref: 10-F390268
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
RKI-1447
CAS:1342278-01-6
RKI-1447 is a potent inhibitor of ROCK1 and ROCK2, with IC50 of 14.5 nM and …
Purity:
Min. 95%
Ref: 3D-BR172011
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
